Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1284781)	12/23/2020 8:00:34 PM
From: ro33	Read Replies (2) \| Respond to of 1575154

I can't have a dialogue on addiction with you. I also think that you are lying about your denial of your obvious support for Trump. Rich

To: Tenchusatsu who wrote (1284781)	12/23/2020 8:24:41 PM
From: rzborusa	Read Replies (1) \| Respond to of 1575154

BTW, I'm still waiting for you to prove to me that a drug addiction is something you can catch like an airborne virus ... Does the circumstances one is born into or conceived in have anything to do with addiction?

To: Tenchusatsu who wrote (1284781)	12/24/2020 1:55:53 AM
From: Heywood40	Read Replies (1) \| Respond to of 1575154

Purdue Pharma would have put OxyContin in the air if they could have. Purdue Pharma, the maker of OxyContin, has agreed to plead guilty to criminal charges related to its marketing of the addictive painkiller, and faces penalties of roughly $8.3 billion. Purdue also pleaded guilty to paying illegal kickbacks to doctors who prescribed OxyContin and to an electronic health records company, Practice Fusion, for targeting physicians with alerts that were intended to increase opioid prescriptions. Practice Fusion has paid $145 million in fines for taking those kickbacks. Doctors overprescribing OxyContin, along with illicit distribution of the drug, have contributed to the deaths of more than 450,000 Americans since 1999.